CASI Pharmaceuticals, Inc. (CASIF)
OTCMKTS
· Delayed Price · Currency is USD
0.210
0.00 (0.00%)
At close: Mar 9, 2026
CASI Pharmaceuticals Employees
CASI Pharmaceuticals had 233 employees as of December 31, 2024. The number of employees increased by 57 or 32.39% compared to the previous year.
Employees
233
Change (1Y)
57
Growth (1Y)
32.39%
Revenue / Employee
$115,219
Profits / Employee
-$211,953
Market Cap
4.32M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vislink Technologies | 105 |
| Clean Vision | 38 |
| Next Meats Holdings | 9 |
| Luminar Technologies | 580 |
| SUIC Worldwide Holdings | 6 |
CASI Pharmaceuticals News
- 12 days ago - CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel - Accesswire
- 7 weeks ago - CASI Pharmaceuticals Announces Approval of Clinical Trial Application by China NMPA for Phase 1 / 2 Study of CID-103 for Renal Allograft Antibody-Mediated Rejection (AMR) - Accesswire
- 2 months ago - CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia - Accesswire
- 2 months ago - CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements - Accesswire
- 3 months ago - CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing - Accesswire
- 3 months ago - CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting - Accesswire
- 3 months ago - CASI Pharmaceuticals Announces Changes in Board Governance - Accesswire
- 4 months ago - CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results - Accesswire